Of mice and humans: How good are HLA transgenic mice as a model of human immune responses?

Immunome Research

Volumn 5, Issue 1, 2009, Pages

  Kotturi, Maya F ^a   Assarsson, Erika ^a   Peters, Bjoern ^a   Grey, Howard ^a   Oseroff, Carla ^a   Pasquetto, Valerie ^a   Sette, Alessandro ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; SMALLPOX VACCINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; FEMALE; HLA SYSTEM; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PATHOGENESIS; SCREENING; T LYMPHOCYTE; TRANSGENIC MOUSE; VACCINATION; VACCINIA; VACCINIA VIRUS;

MUS; MUS MUSCULUS; VACCINIA VIRUS;

EID: 68149117283     PISSN: None     EISSN: 17457580     Source Type: Journal    
DOI: 10.1186/1745-7580-5-3     Document Type: Article

References (34)

1. Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection. SJ Wu CG Hayes DR Dubois MG Windheuser YH Kang DM Watts DG Sieckmann, Am J Trop Med Hyg 1995 52 468 476 7771614
2. Definition of a human T cell epitope from influenza A non-structural protein 1 using HLA-A2.1 transgenic mice. S Man MH Newberg VL Crotzer CJ Luckey NS Williams Y Chen EL Huczko JP Ridge VH Engelhard, Int Immunol 1995 7 597 605 10.1093/intimm/7.4.597 7547687
3. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. M Shirai T Arichi M Nishioka T Nomura K Ikeda K Kawanishi VH Engelhard SM Feinstone JA Berzofsky, J Immunol 1995 154 2733 2742 7533182
4. Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice. PA Wentworth A Vitiello J Sidney E Keogh RW Chesnut H Grey A Sette, Eur J Immunol 1996 26 97 101 10.1002/eji.1830260115 8566090
5. HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. V Pasquetto HH Bui R Giannino C Banh F Mirza J Sidney C Oseroff DC Tscharke K Irvine JR Bennink B Peters S Southwood V Cerundolo H Grey JW Yewdell A Sette, J Immunol 2005 175 5504 5515 16210659
6. Species-specific differences in proteasomal processing and tapasin-mediated loading influence peptide presentation by HLA-B27 in murine cells. L Sesma I Alvarez M Marcilla A Paradela JA Lopez de Castro, J Biol Chem 2003 278 46461 46472 10.1074/jbc.M308816200 12963723
7. Differential processing of influenza nucleoprotein in human and mouse cells. VM Braud AJ McMichael V Cerundolo, Eur J Immunol 1998 28 625 635 10.1002/(SICI)1521-4141(199802)28:02<625::AID-IMMU625>3.0.CO;2-I 9521073
8. A detailed analysis of the murine TAP transporter substrate specificity. A Burgevin L Saveanu Y Kim E Barilleau M Kotturi A Sette P van Endert B Peters, PLoS ONE 2008 3 e2402 18545702 10.1371/journal.pone.0002402
9. HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation. C Oseroff F Kos HH Bui B Peters V Pasquetto J Glenn T Palmore J Sidney DC Tscharke JR Bennink S Southwood HM Grey JW Yewdell A Sette, Proc Natl Acad Sci USA 2005 102 13980 13985 16172378 10.1073/pnas.0506768102
10. HLA-A2-restricted human CD8(+) cytotoxic T lymphocyte responses to a novel epitope in vaccinia virus that is conserved among orthopox viruses. Y Dong TN Denny, J Infect Dis 2006 194 168 175 10.1086/505224 16779722
11. Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7. M Terajima J Cruz AM Leporati WE Demkowicz Jr JS Kennedy FA Ennis, Hum Immunol 2006 67 512 520 10.1016/j.humimm.2005.12.004 16829305
12. Human T-cell responses to vaccinia virus envelope proteins. J Tang M Murtadha M Schnell LC Eisenlohr J Hooper P Flomenberg, J Virol 2006 80 10010 10020 17005679 10.1128/JVI.00601-06
13. A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection. E Assarsson J Sidney C Oseroff V Pasquetto HH Bui N Frahm C Brander B Peters H Grey A Sette, J Immunol 2007 178 7890 7901 17548627
14. Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara. CL Smith F Mirza V Pasquetto DC Tscharke MJ Palmowski PR Dunbar A Sette AL Harris V Cerundolo, J Immunol 2005 175 8431 8437 16339586
15. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses. JT Snyder IM Belyakov A Dzutsev F Lemonnier JA Berzofsky, J Virol 2004 78 7052 7060 15194781 10.1128/JVI.78.13.7052-7060.2004
16. Identification of vaccinia virus epitope-specific HLA-A*0201- restricted T cells and comparative analysis of smallpox vaccines. I Drexler C Staib W Kastenmuller S Stevanovic B Schmidt FA Lemonnier HG Rammensee DH Busch H Bernhard V Erfle G Sutter, Proc Natl Acad Sci USA 2003 100 217 222 12518065 10.1073/pnas.262668999
17. Using HLA-transgenic mice to identify immunodominant human CD8+ T cell epitopes does (genome) size matter? M Terajima FA Ennis, Immunol Lett 2006 105 97 98 10.1016/j.imlet.2006.01.007 16494950
18. Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses. M Terajima J Cruz G Raines ED Kilpatrick JS Kennedy AL Rothman FA Ennis, J Exp Med 2003 197 927 932 12668642 10.1084/jem.20022222
19. HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. S Pascolo N Bervas JM Ure AG Smith FA Lemonnier B Perarnau, J Exp Med 1997 185 2043 2051 9182675 10.1084/jem.185.12. 2043
20. Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes. S Corbet HV Nielsen L Vinner S Lauemoller D Therrien S Tang G Kronborg L Mathiesen P Chaplin S Brunak S Buus A Fomsgaard, J Gen Virol 2003 84 2409 2421 10.1099/vir.0.19152-0 12917462
21. Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses. GT Belz CM Smith D Eichner K Shortman G Karupiah FR Carbone WR Heath, J Immunol 2004 172 1996 2000 14764661
22. Regulation of maturation and activating potential in CD8+ versus CD8-dendritic cells following in vivo infection with vaccinia virus. RD Yammani S Pejawar-Gaddy TC Gurley ET Weimer EM Hiltbold MA Alexander-Miller, Virology 2008 378 142 150 10.1016/j.virol.2008.05.031 18586296
23. Vaccinia virus induces strong immunoregulatory cytokine production in healthy human epidermal keratinocytes: a novel strategy for immune evasion. L Liu Z Xu RC Fuhlbrigge V Pena-Cruz J Lieberman TS Kupper, J Virol 2005 79 7363 7370 15919891 10.1128/JVI.79.12.7363-7370.2005
24. Susceptibility of different leukocyte cell types to Vaccinia virus infection. JM Sanchez-Puig L Sanchez G Roy R Blasco, Virol J 2004 1 10 15555076 10.1186/1743-422X-1-10
25. Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve. C Oseroff B Peters V Pasquetto M Moutaftsi J Sidney V Panchanathan DC Tscharke B Maillere H Grey A Sette, J Immunol 2008 180 7193 7202 18490718
26. Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. HC Probst K Tschannen A Gallimore M Martinic M Basler T Dumrese E Jones MF van den Broek, J Immunol 2003 171 5415 5422 14607945
27. Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling. VS Meyer W Kastenmuller G Gasteiger M Franz-Wachtel T Lamkemeyer HG Rammensee S Stevanovic D Sigurdardottir I Drexler, J Immunol 2008 181 6371 6383 18941228
28. Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes. E Assarsson JA Greenbaum M Sundstrom L Schaffer JA Hammond V Pasquetto C Oseroff RC Hendrickson EJ Lefkowitz DC Tscharke J Sidney HM Grey SR Head B Peters A Sette, Proc Natl Acad Sci USA 2008 105 2140 2145 18245380 10.1073/pnas.0711573105
29. Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance. MF Kotturi I Scott T Wolfe B Peters J Sidney H Cheroutre MG von Herrath MJ Buchmeier H Grey A Sette, J Immunol 2008 181 2124 2133 18641351
30. Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans. M Terajima L Orphin AM Leporati P Pazoles J Cruz AL Rothman FA Ennis, Hum Immunol 2008 69 815 825 10.1016/j.humimm.2008.09.009 18955096
31. Measurement of MHC/peptide interactions by gel filtration. J Sidney S Southwood C Oseroff MFD Guercio A Sette H Grey, Current Protocols in Immunology I New York: John Wiley & Sons, Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, 1998 18.13.11 18.13.19
32. Isolation of whole mononuclear cells from peripheral blood and cord blood. ME Kanof PD Smith H Zola, Curr Protoc Immunol 2001 Chapter 7 Unit 7 1 18432823
33. Derivation of HLA-B*0702 transgenic mice: functional CTL repertoire and recognition of human B*0702-restricted CTL epitopes. J Alexander C Oseroff J Sidney A Sette, Hum Immunol 2003 64 211 223 10.1016/S0198-8859(02) 00786-3 12559623
34. Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes. J Alexander C Oseroff J Sidney P Wentworth E Keogh G Hermanson FV Chisari RT Kubo HM Grey A Sette, J Immunol 1997 159 4753 4761 9366399